NO975773L - Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved - Google Patents

Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved

Info

Publication number
NO975773L
NO975773L NO975773A NO975773A NO975773L NO 975773 L NO975773 L NO 975773L NO 975773 A NO975773 A NO 975773A NO 975773 A NO975773 A NO 975773A NO 975773 L NO975773 L NO 975773L
Authority
NO
Norway
Prior art keywords
substances
dry
methods
compositions obtained
foamed glass
Prior art date
Application number
NO975773A
Other languages
English (en)
Norwegian (no)
Other versions
NO975773D0 (no
Inventor
Bruce Joseph Roser
Enda Martin Gribbon
Original Assignee
Quadrant Holdings Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975773(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadrant Holdings Cambridge filed Critical Quadrant Holdings Cambridge
Publication of NO975773D0 publication Critical patent/NO975773D0/no
Publication of NO975773L publication Critical patent/NO975773L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO975773A 1995-06-07 1997-12-08 Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved NO975773L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (2)

Publication Number Publication Date
NO975773D0 NO975773D0 (no) 1997-12-08
NO975773L true NO975773L (no) 1998-02-03

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975773A NO975773L (no) 1995-06-07 1997-12-08 Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved

Country Status (22)

Country Link
EP (1) EP0831790B1 (de)
JP (1) JP4502406B2 (de)
KR (1) KR19990022710A (de)
CN (1) CN1245957C (de)
AP (1) AP852A (de)
AT (1) ATE239451T1 (de)
AU (1) AU713599B2 (de)
BR (1) BR9609188A (de)
CA (1) CA2223438C (de)
CZ (1) CZ391297A3 (de)
DE (1) DE69628007T2 (de)
DK (1) DK0831790T3 (de)
ES (1) ES2194992T3 (de)
HU (1) HUP9901716A3 (de)
IL (1) IL122482A (de)
MX (1) MX9709716A (de)
NO (1) NO975773L (de)
NZ (1) NZ309841A (de)
PL (1) PL184823B1 (de)
PT (1) PT831790E (de)
SK (1) SK167597A3 (de)
WO (1) WO1996040077A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332105T2 (de) 1992-09-29 2003-03-06 Inhale Therapeutic Systems, San Carlos Pulmonale abgabe von aktiven fragmenten des parathormons
EP0748213B1 (de) 1994-03-07 2004-04-14 Nektar Therapeutics Verfahren und mittel zur verabreichung von insulin über die lunge
CN1188171C (zh) 1994-06-02 2005-02-09 廓德伦特控股剑桥有限公司 防止各种特质在再水化或熔化时聚集的方法以及由此获得的组合物
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
AU5459698A (en) * 1997-11-26 1999-06-15 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1071465A1 (de) * 1998-03-18 2001-01-31 Ronai, Peter Amorphe gläser zur stabilisierung von empfindlichen produkten
US6306345B1 (en) * 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
CN1433465A (zh) * 1999-05-04 2003-07-30 埃里克·爱德华·沃勒尔 保存病毒和支原体的方法
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
CA2382061A1 (en) * 1999-08-19 2001-02-22 Victor Bronshtein Preservation of bacterial cells at ambient temperatures
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1296656E (pt) 2000-06-27 2006-12-29 Hoffmann La Roche Processo para a preparação de uma composição
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
WO2003041637A2 (en) * 2001-11-09 2003-05-22 Centocor, Inc. Lyophilized monoclonal antibody compositions
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
DK1556477T3 (en) * 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
EP1428526A1 (de) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Zusammensetzung zur schnellen Freisetzung von lipophilen Stoffen
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
EP1758937B1 (de) * 2004-05-24 2009-09-02 Genvault Corporation Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form
EP1750760B1 (de) 2004-06-02 2017-06-28 Universal Stabilization Technologies, Inc. Konservierung mittels verdampfung
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1973406B1 (de) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation Abgabekonstituens für probiotische bakterien umfassend eine trockene matrix aus polysacchariden, sacchariden und polyolen in glasform
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
KR101540920B1 (ko) 2007-07-26 2015-08-03 사노피 파스퇴르 리미티드 항원-애주번트 조성물 및 방법
US8283165B2 (en) 2008-09-12 2012-10-09 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
KR101799983B1 (ko) 2009-05-26 2017-12-20 어드밴스드 바이오뉴트리션 코프. 생물학적 활성 미생물 및/또는 생활성 물질을 포함하는 안정한 건식분말 조성물 및 제조 방법
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
EP3449938A1 (de) * 2011-05-17 2019-03-06 Soligenix, Inc. Wärmestabile impfstoffzusammensetzungen und verfahren zur herstellung davon
PE20191242A1 (es) 2011-10-25 2019-09-16 Prothena Biosciences Ltd Formulaciones de anticuerpo y metodos
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês
ES2818569T3 (es) * 2015-09-09 2021-04-13 Drawbridge Health Inc Métodos para la recopilación, estabilización y conservación de muestras
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
SG10201911879UA (en) 2017-01-10 2020-01-30 Drawbridge Health Inc Devices, systems, and methods for sample collection
CN117050969B (zh) * 2023-08-18 2024-04-02 北京中检葆泰生物技术有限公司 一种碱性磷酸酶的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
JPS6115830A (ja) * 1984-06-28 1986-01-23 ザ　プロクタ−　アンド　ガンブル　カンパニ− 制酸剤組成物およびその製造方法
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
AU634227B2 (en) * 1989-05-01 1993-02-18 Baxter International Inc. Composition of beneficial agent and method for administering the same by controlled dissolution
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
ES2090714T3 (es) * 1991-12-05 1996-10-16 Mallinckrodt Veterinary Inc Matriz de vidrio de carbohidrato para la liberacion prolongada de un agente terapeutico.
ES2096103T3 (es) * 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica

Also Published As

Publication number Publication date
DE69628007T2 (de) 2003-11-27
CN1193908A (zh) 1998-09-23
IL122482A (en) 1999-10-28
EP0831790B1 (de) 2003-05-07
JP4502406B2 (ja) 2010-07-14
PT831790E (pt) 2003-07-31
CN1245957C (zh) 2006-03-22
AP852A (en) 2000-06-16
HUP9901716A2 (hu) 1999-09-28
NO975773D0 (no) 1997-12-08
HUP9901716A3 (en) 2000-04-28
MX9709716A (es) 1998-03-31
CA2223438C (en) 2008-05-13
AP9701151A0 (en) 1998-01-31
SK167597A3 (en) 1998-10-07
AU713599B2 (en) 1999-12-09
CA2223438A1 (en) 1996-12-19
KR19990022710A (ko) 1999-03-25
ES2194992T3 (es) 2003-12-01
JPH11506467A (ja) 1999-06-08
DK0831790T3 (da) 2003-09-01
AU6009896A (en) 1996-12-30
CZ391297A3 (cs) 1998-05-13
ATE239451T1 (de) 2003-05-15
WO1996040077A3 (en) 1997-01-23
EP0831790A2 (de) 1998-04-01
IL122482A0 (en) 1998-06-15
BR9609188A (pt) 1999-05-11
PL323902A1 (en) 1998-04-27
DE69628007D1 (de) 2003-06-12
WO1996040077A2 (en) 1996-12-19
NZ309841A (en) 1999-10-28
PL184823B1 (pl) 2002-12-31

Similar Documents

Publication Publication Date Title
NO975773L (no) Fremgangsmåter for stabil innarbeiding av substanser i törre, skummede glass-grunnmasser, og sammensetninger oppnådd derved
DE68919911D1 (de) Chlordioxyd enthaltende Zusammensetzungen und ihre Herstellung.
DE69721151D1 (de) Kieselsäuregefüllte Kautschukzusammensetzungen und ihre Herstellung
DE69715482D1 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
AU7529096A (en) Substituted aryl pyrroles, compositions containing such compounds and methods of use
NO894173L (no) Fremgangsmaate ved fremstilling av kloridoksid.
NO992504L (no) Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse
AU5376996A (en) Low temperature composition preparation device, and methods of constructing and utilizing same
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
AU7961498A (en) 9a-azalides, compositions containing such compounds and methods of treatment
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
DE69602903D1 (de) Herstellung von Glaszusammensetzungen
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
AU5126090A (en) Thermally stable fluorinated organosiloxane gel composition
NO973408L (no) Fremgangsmåte til fremstilling av alkyl-tert.butyletere og di-n-buten fra feltbutaner
AU7995600A (en) Compositions and methods for the incorporation of chemical substances into cells
DE68914700D1 (de) Polymere Zusammensetzungen und ihre Herstellung.
DE69730766D1 (de) Maltooligosyltaranose und Maltooligosylparatinose enthaltende Polysaccharidzusammensetzung, Herstellung und Verwendung
NO973410L (no) Fremgangsmåte til fremstilling av di-n-buten og alkyl-tert.butyletere fra feltbutaner
EP0799636A3 (de) Schäumende Trockenzusammensetzung und ihre Verwendung
FI964829A0 (fi) Menetelmä 2,2,4-trimetyyli-1,3-pentaanidioli-isobutyraatin valmistamiseksi
NO20001176D0 (no) Anvendelse av blandinger av polymerer og aminoisothiasoler som biocider
AU8147598A (en) 8a-azalides, compositions containing such compounds and methods of treatment
AU5341098A (en) Fulgimide compounds, use of them, and compositions containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application